Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Marks

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
American Journal of Clinical Oncology|January 22, 2002
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group TrialG Colon-Otero, R D Niedringhaus, S H Hillman, et al.
European Review for Medical and Pharmacological Sciences|December 19, 2023
Unleashing the potential of biotechnology for sustainable developmentK Donato, M C Medori, L Stuppia, et al.
European Review for Medical and Pharmacological Sciences|December 19, 2023
Achievement of sustainable development goals through the Mediterranean dietM C Medori, K Donato, L Stuppia, et al.
European Review for Medical and Pharmacological Sciences|April 3, 2024
Author Correction: Achievement of sustainable development goals through the Mediterranean dietM C Medori, K Donato, L Stuppia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinibA S Mansfield, S J Murphy, F R Harris, et al.
Cancer Research|April 15, 2000
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activityA A Adjei, C Erlichman, J N Davis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 1, 1999
Alpha1-antitrypsin deficiency allele carriers among lung cancer patientsP Yang, K A Wentzlaff, J A Katzmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancerJ A Bonner, J A Sloan, K M Rowland, et al.
Cancer|October 24, 1997
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvementT E Sawyer, J A Bonner, P M Gould, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinomaJ A Bonner, J A Sloan, T G Shanahan, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
American Journal of Clinical Oncology|January 22, 2002
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group TrialG Colon-Otero, R D Niedringhaus, S H Hillman, et al.
European Review for Medical and Pharmacological Sciences|December 19, 2023
Unleashing the potential of biotechnology for sustainable developmentK Donato, M C Medori, L Stuppia, et al.
European Review for Medical and Pharmacological Sciences|December 19, 2023
Achievement of sustainable development goals through the Mediterranean dietM C Medori, K Donato, L Stuppia, et al.
European Review for Medical and Pharmacological Sciences|April 3, 2024
Author Correction: Achievement of sustainable development goals through the Mediterranean dietM C Medori, K Donato, L Stuppia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinibA S Mansfield, S J Murphy, F R Harris, et al.
Cancer Research|April 15, 2000
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activityA A Adjei, C Erlichman, J N Davis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 1, 1999
Alpha1-antitrypsin deficiency allele carriers among lung cancer patientsP Yang, K A Wentzlaff, J A Katzmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancerJ A Bonner, J A Sloan, K M Rowland, et al.
Cancer|October 24, 1997
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvementT E Sawyer, J A Bonner, P M Gould, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinomaJ A Bonner, J A Sloan, T G Shanahan, et al.
Pageof 4